title: Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes.
authors.affiliation: Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
authors.forename: Kouichi
authors.initials: K
authors.lastname: Tamura
authors.affiliation: Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
authors.forename: Hiromichi
authors.initials: H
authors.lastname: Wakui
authors.affiliation: Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
authors.forename: Kengo
authors.initials: K
authors.lastname: Azushima
authors.affiliation: Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
authors.forename: Kazushi
authors.initials: K
authors.lastname: Uneda
authors.affiliation: Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Umemura
mesh_terms: D001794:Blood Pressure / Q000187:drug effects*; D002940:Circadian Rhythm / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors
references.citation: Hypertens Res. 2015 Jun;38(6):367-74
references.pmid: 25762415
references.citation: Kidney Int. 2003 Jan;63(1):225-32
references.pmid: 12472787
references.citation: Clin Exp Hypertens. 2009 May;31(3):259-70
references.pmid: 19387902
references.citation: Diabetes Care. 2012 Jun;35(6):1364-79
references.pmid: 22517736
references.citation: Kidney Int. 2013 Mar;83(3):517-23
references.pmid: 23302714
references.citation: N Engl J Med. 2008 Feb 7;358(6):580-91
references.pmid: 18256393
references.citation: Clin Exp Hypertens. 2008 Jan;30(1):33-43
references.pmid: 18214732
references.citation: J Clin Endocrinol Metab. 2010 Jan;95(1):34-42
references.pmid: 19892839
references.citation: Eur Heart J. 2011 Jun;32(12 ):1493-9
references.pmid: 21421598
references.citation: Diabetes Care. 2015 Mar;38(3):420-8
references.pmid: 25271206
references.citation: Hypertens Res. 2014 Apr;37(4):253-390
references.pmid: 24705419
references.citation: J Hypertens. 2007 Dec;25(12):2479-85
references.pmid: 17984670
references.citation: N Engl J Med. 2015 Nov 26;373(22):2117-28
references.pmid: 26378978
references.citation: Diabetologia. 2011 Jan;54(1):32-43
references.pmid: 20668832
references.citation: J Am Soc Nephrol. 2009 Aug;20(8):1813-21
references.pmid: 19443635
references.citation: Hypertens Res. 2015 Dec;38(12):889-94
references.pmid: 26311166
references.citation: Hypertens Res. 2016 Feb;39(2):113-8
references.pmid: 26606874
references.citation: Clin Exp Nephrol. 2014 Aug;18(4):613-20
references.pmid: 24132561
references.citation: Hypertens Res. 2016 Jun;39(6):415-22
references.pmid: 26818652
references.citation: JAMA. 2015 Sep 1;314(9):884-94
references.pmid: 26325557
references.citation: BMJ. 2011 Jul 26;343:d4169
references.pmid: 21791495
references.citation: Am J Hypertens. 2009 Jan;22(1):46-51
references.pmid: 18833198